Imatinib for chronic myeloid leukemia: The impact of its effectiveness and long-term side effects

B. Douglas Smith

doi:10.1093/jnci/djr073

Imatinib for chronic myeloid leukemia: The impact of its effectiveness and long-term side effects

B. Douglas Smith

School of Medicine

Research output: Contribution to journal › Editorial › peer-review

21 Scopus citations

Original language	English (US)
Pages (from-to)	527-529
Number of pages	3
Journal	Journal of the National Cancer Institute
Volume	103
Issue number	7
DOIs	https://doi.org/10.1093/jnci/djr073
State	Published - Apr 6 2011

ASJC Scopus subject areas

Oncology
Cancer Research

Access to Document

10.1093/jnci/djr073

Cite this

@article{30e101048cbb488c8d4060abab308a49,

title = "Imatinib for chronic myeloid leukemia: The impact of its effectiveness and long-term side effects",

author = "Smith, {B. Douglas}",

year = "2011",

month = apr,

day = "6",

doi = "10.1093/jnci/djr073",

language = "English (US)",

volume = "103",

pages = "527--529",

journal = "Journal of the National Cancer Institute",

issn = "0027-8874",

publisher = "Oxford University Press",

number = "7",

}

TY - JOUR

T1 - Imatinib for chronic myeloid leukemia

T2 - The impact of its effectiveness and long-term side effects

AU - Smith, B. Douglas

PY - 2011/4/6

Y1 - 2011/4/6

UR - http://www.scopus.com/inward/record.url?scp=79953841924&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79953841924&partnerID=8YFLogxK

U2 - 10.1093/jnci/djr073

DO - 10.1093/jnci/djr073

M3 - Editorial

C2 - 21422404

AN - SCOPUS:79953841924

SN - 0027-8874

VL - 103

SP - 527

EP - 529

JO - Journal of the National Cancer Institute

JF - Journal of the National Cancer Institute

IS - 7

ER -

Imatinib for chronic myeloid leukemia: The impact of its effectiveness and long-term side effects

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this